Artia Global Partners’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Artia Global Partners’s Portfolio ISEE Stock Details ISEE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-244,861	Closed	-$9.63M	–	34
2023 Q2	$9.63M	Sell	244,861 -159,754	-39%	-$5.64M	3.32%	10
2023 Q1	$9.84M	Sell	404,615 -100,000	-20%	-$2.19M	3.64%	10
2022 Q4	$10.8M	Buy	+504,615	New	+$10.8M	4.12%	8

Artia Global Partners's ISEE Position: Q3 2023 in Review

Artia Global Partners sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q3 2023, closing a stake of 244,861 shares — an estimated $9.63M sold.

Artia Global Partners first reported a position in ISEE in Q4 2022 and held it in 3 quarters. The position peaked at $10.8M in Q4 2022. 0 funds tracked by Wall St. Rank hold ISEE as of Q3 2023.

Artia Global Partners reported no remaining IVERIC bio, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Artia Global Partners sold 244,861 IVERIC bio, Inc. Common Stock shares in Q3 2023, an estimated $9.63M.
Artia Global Partners first reported a position in IVERIC bio, Inc. Common Stock in Q4 2022 and held it in 3 quarters.
Artia Global Partners's IVERIC bio, Inc. Common Stock position peaked at $10.8M in Q4 2022.
0 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q3 2023.

Based on Artia Global Partners's 13F filing for Q3 2023, filed 14 Nov 2023.